<DOC>
	<DOCNO>NCT00021801</DOCNO>
	<brief_summary>The goal islet cell transplantation Type 1 diabetic provide affect constant normal blood glucose level , thereby reduce eliminate altogether need injected insulin . This normalization may prevent slow progression diabetic complication , result healthier lifestyle , lead good quality life . Participants meet inclusion criterion undergo extensive screening process typically include series blood test , EKG , chest x-ray , psychological evaluation , among others . Those eligible chose participate trial receive islet cell transplant bone marrow infusion donor , together follow immunosuppressive medication : tacrolimus , sirolimus , daclizumab infliximab . Because bone marrow infusion may successfully prevent transplanted islet cell reject , participant may able stop take immunosuppressive medication year . The islet cell transplant do local anesthesia special procedure radiology room . Several day islet cell transplant , participant admit hospital outpatient order receive bone marrow via simple intra-venous infusion procedure . All participant need see Diabetes Research Institute transplant follow-up test post-islet cell transplant care .</brief_summary>
	<brief_title>Islet Cell Transplantation Alone CD34+ Enriched Bone Marrow Cell Infusion Patients With Diabetes Mellitus : Steroid-Free Regimen</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Candidates must age 18 50 . Candidates must insulindependent diabetes mellitus ( IDDM ) least 5 year physician care least 6 month prior enrollment trial . Eligible candidate poorly control IDDM manifest sign symptom severe enough incapacitating . These symptom include episode hypoglycemic unawareness ( failure recognize blood glucose level &lt; 54 mg/dl ) episodes require assistance others . Candidates may poor diabetes control despite intensive insulin therapy ( HbA1c &gt; 8.0 % ) . Creatinine clearance &gt; 60 ml/min ) Body Mass Index less 26 Women childbearing age must negative pregnancy test agree follow effective contraceptive measure duration trial . Previous concurrent organ transplant Previous concurrent malignancy Untreated proliferative diabetic retinopathy Unstable cardiovascular status , include positive stress echocardiography ( &gt; age 35 ) Active infection , include xray evidence pulmonary infection Peptic ulcer disease , gall stone , portal hypertension Abnormal liver function test Presence panel reactive antibody &gt; 20 % Creatinine clearance &lt; 60 ml/min HbA1c &gt; 12 % Serological evidence HIV , HbsAg , HCV Anemia ( hemoglobin &lt; 12.0 ) Any condition circumstance , include psychogenic factor , preclude therapeutic compliance otherwise make unsafe undergo islet cell transplant . PSA &gt; 4 male</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Type I Diabetes Mellitus</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Islet Cell Transplant</keyword>
	<keyword>Percutaneous Transhepatic Portal</keyword>
</DOC>